Understanding The Role of NPAT in Psychiatric Disorders (G4863)

Target Name: NPAT

NCBI ID: G4863

NPAT

Understanding The Role of NPAT in Psychiatric Disorders

NPAT, or neuropeptide-converting enzyme type 2, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the regulation of neurotransmitter release from neurons, and is involved in the production of several neurotransmitters, including dopamine, serotonin, and endocannabinoids. NPAT is also involved in the breakdown of neurotransmitters, which is important for maintaining the homeostasis of neurotransmitter levels in the brain.

The research on NPAT has been primarily focused on its role in the regulation of psychiatric and neurological disorders. Studies have shown thatNPAT is often reduced in individuals with major depressive disorder (MDD), and that increasing levels of NPAT has been associated with improved symptoms of MDD. Additionally,NPAT has also been shown to be involved in the regulation of anxiety disorders, and that individuals with anxiety disorders may have lower levels of NPAT.

In addition to its role in the regulation of neurotransmitter levels, NPAT has also been shown to be involved in the regulation of pain. Studies have shown that NPAT is involved in the production of pain modulators, such as endocannabinoids, which are involved in the regulation of pain perception. Additionally,NPAT has also been shown to be involved in the regulation of inflammation, and that it has anti-inflammatory effects.

Despite the promising research on NPAT, more research is needed to fully understand its role in the regulation of psychiatric and neurological disorders. Additionally, the development of new drugs or biomarkers that target NPAT would be a valuable addition to the treatment options for these disorders.

Protein Name: Nuclear Protein, Coactivator Of Histone Transcription

Functions: Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters

The "NPAT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPAT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets